Abeona Therapeutics, Inc. (ABEO)
5.30
-0.02
(-0.38%)
USD |
NASDAQ |
May 21, 09:32
Abeona Therapeutics EPS Diluted (Quarterly) : -0.3016 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.182 |
| Plus Therapeutics, Inc. | -1.045 |
| Perspective Therapeutics, Inc. | -0.2528 |
| Myriad Genetics, Inc. | -0.3639 |
| Atossa Therapeutics, Inc. | -1.112 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.08M |
| Revenue (Quarterly) | 8.72M |
| Total Expenses (Quarterly) | 25.80M |
| Enterprise Value | 158.12M |
| Gross Profit Margin (Quarterly) | 59.12% |
| Profit Margin (Quarterly) | -195.8% |
| Earnings Yield | 17.68% |
| Normalized Earnings Yield | 16.46 |